Core Viewpoint - Wanfu Biology (300482.SZ) has announced that it currently does not have any products for detecting rhinoviruses, but is responding to the potential flu peak by launching an integrated respiratory pathogen detection solution that combines reagents, instruments, and information systems to reduce patient wait times and assist medical institutions in managing the flu testing peak [1] Group 1 - The company is introducing a comprehensive solution aimed at addressing the characteristics of the current flu season [1] - The solution is designed to shorten patient waiting times and support healthcare institutions in handling the peak of flu testing [1] - The company has both online and offline sales and promotion channels to meet market demands [1] Group 2 - The company's operational strategy will adjust according to market demand [1]
万孚生物(300482.SZ):暂无鼻病毒相关检测产品